Inhibitors of NID67 encompass a diverse array of compounds that exert their effects through a variety of cellular mechanisms, each leading to the downregulation of NID67 activity. Some inhibitors target kinase signaling pathways, which are critical for the phosphorylation and subsequent regulation of integral membrane proteins. By obstructing these kinases, the phosphorylation state and activity of NID67 can be significantly reduced. Other inhibitors act by modulating the lipid signaling environment within cellular membranes, where NID67 resides. These inhibitors can disrupt the normal functioning of NID67 by altering the lipid composition and signaling dynamics of the membrane, leading to decreased protein activity. Additionally, there are inhibitors that interfere with the trafficking of membrane proteins, which can be crucial for the proper localization and function of NID67. By inhibiting the protein transport machinery, these compounds can prevent NID67 from reaching its functional destination within the cell, thus effectively reducing its activity.
Furthermore, inhibitors that modulate calcium signaling pathways offer another avenue to attenuate NID67 activity. Calcium ions play a pivotal role in numerous signaling cascades, and the disruption of calcium homeostasis can indirectly impact the function of calcium-dependent proteins like NID67. For instance, inhibition of calcium channel activities or calcineurin, an enzyme important for calcium-dependent dephosphorylation processes, can lead to a decrease in NID67 activity. Also, antagonists of proteins that interact with calcium, such as calmodulin, can lead to a reduction in NID67 activity if the protein's function is modulated by calcium-calmodulin-dependent processes.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
A potent kinase inhibitor that acts on various kinases that could phosphorylate NID67, hence preventing any phosphorylation-based regulation of NID67 activity. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
An isoflavone that inhibits tyrosine kinases, potentially affecting the phosphorylation state of NID67 or its interacting partners, leading to decreased NID67 activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A phosphoinositide 3-kinases (PI3K) inhibitor that could alter the lipid signaling milieu of the membrane, potentially disrupting NID67’s membrane-associated functions. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
Inhibits calcineurin, likely impacting calcium-dependent dephosphorylation processes that might regulate NID67 function. | ||||||
2-APB | 524-95-8 | sc-201487 sc-201487A | 20 mg 100 mg | $28.00 $53.00 | 37 | |
Modulates store-operated calcium entry, which could indirectly affect the calcium-dependent signaling pathways regulating NID67 activity. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Inhibits protein transport from the endoplasmic reticulum to the Golgi apparatus, potentially disrupting the trafficking and therefore the function of membrane proteins like NID67. | ||||||
Chelerythrine | 34316-15-9 | sc-507380 | 100 mg | $540.00 | ||
A potent inhibitor of protein kinase C (PKC) that would prevent PKC-mediated phosphorylation events, potentially affecting the activity of NID67 if it is regulated by PKC signaling. | ||||||
W-7 | 61714-27-0 | sc-201501 sc-201501A sc-201501B | 50 mg 100 mg 1 g | $166.00 $306.00 $1675.00 | 18 | |
A calmodulin antagonist that could disrupt any calmodulin-mediated processes involving NID67. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Inhibits the sarco/endoplasmic reticulum Ca2+-ATPase (SERCA), leading to depletion of ER calcium stores, which could indirectly affect NID67 function if it is involved in calcium signaling. | ||||||
Gö 6983 | 133053-19-7 | sc-203432 sc-203432A sc-203432B | 1 mg 5 mg 10 mg | $105.00 $299.00 $474.00 | 15 | |
A broad-spectrum PKC inhibitor that could prevent PKC-mediated phosphorylation events and therefore potentially decrease NID67 activity. | ||||||